WPI 3355 (Nateglinide 120 mg)
Pill with imprint WPI 3355 is Pink, Capsule-shape and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc.
Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3355
Nateglinide
- Imprint
- WPI 3355
- Strength
- 120 mg
- Color
- Pink
- Size
- 17.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories Inc.
- National Drug Code (NDC)
- 00591-3355
- Inactive Ingredients
-
silicon dioxide,
fumaric acid,
hypromellose 2910 (3 mPa.s),
lactose monohydrate,
magnesium stearate,
polysorbate 80,
sodium starch glycolate type A potato,
corn starch,
titanium dioxide,
hypromellose 2910 (6 mPa.s),
FD&C Red No. 40,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about nateglinide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (4)
- Drug images
- Pricing & coupons
- En español
- Drug class: meglitinides
Patient resources
- Other brands
- Starlix
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.